For its fourth fiscal quarter (ending December 31), Archer-Daniels-Midland Co (NYSE: ADM) has reported a -41% decline in E.P.S. from $1.84 a year ago to $1.08 in the current quarter. This performance was $-0.35 short […]
BUSINESS Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers […]
Cardiff Oncology Inc (NASDAQ: CRDF) stock closed at $4.48 on 3/12/24 after a major increase of 10.9%. NORMAL trading volume accompanied the advance. The stock has risen 28.4% during the last week and has been […]
What is the market’s view of ANI Pharmaceuticals’ future operating performance as reflected in the current price of $69? Over the next 6 years, ANI Pharmaceuticals shares will need to reach $116 to achieve average […]
BUSINESS El Pollo Loco Holdings, Inc., through its subsidiary, El Pollo Loco, Inc., develops, franchises, licenses, and operates quick-service restaurants under the El Pollo Loco name. As of May 04, 2022, the company operated 480 […]
Innodata Inc (NASDAQ: INOD) stock closed at $5.99 on 3/12/24 after a major decline of -16.3%. Moreover, this decline was accompanied by unusually high trading volume at 165% of normal. The stock has declined -17.9% […]
Cryoport Inc (NASDAQ: CYRX) has reported a loss for its fourth fiscal quarter (ending December 31) of $-1.31 versus a loss $-0.24 for the same period a year ago. This result fell short of the […]
Braskem SA (NYSE: BAK). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, and its shorter term price trend turned down. Meaningful negative changes […]
At the current price of $41, what are market expectations regarding Ally Financial’s future operating performance? Over the next 6 years, Ally Financial shares will need to reach $68 to achieve average annual stock market […]
Ultralife Corp (NASDAQ: ULBI) stock suffered a major decline of -11.0% on 3/12/24. The shares closed at $8.71. Moreover, exceptionally high trading volume at 241% of normal accompanied the decline. The stock has been exceptionally […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research